108
Views
0
CrossRef citations to date
0
Altmetric
Free Communications Biology and Biochemistry

Production of breast cancer cell lines expressing viral gene VIF

, , , &
Page 39 | Received 13 Oct 2018, Accepted 12 Dec 2018, Published online: 28 May 2019
 

Abstract

Introduction: Virion Infectivity factor (Vif) is a protein required for lentiviruses successful infection of human target cells, through the degradation of host restriction factors, APOBEC3 [Citation1]. In the last years, the activity of APOBEC3 deaminases has also been associated with mutation patterns found in cancer cells, including breast cancer cells [Citation2]. We hypothesize that Vif protein can be used to inhibit APOBEC3 avoiding breast cancer progression and resistance to chemotherapy. This hypothesis should be tested in breast cancer cells expressing Vif proteins from HIV-1 (Vif1), and HIV-2 (Vif2) treated with chemotherapy agents. The aim of this work was the production of breast cell lines expressing constitutively Vif1 and Vif 2 proteins, using lentiviruses as a gene-delivering system.

Materials and methods: Vif1 and Vif2 delivering lentivirus vectors were obtained using the fourth generation lentiviral packaging systems (Clontech). Briefly, Vif 1 and Vif 2 genes were cloned in a bicistronic lentiviral expression vector (pLVX-IRES-zsGreen1) which allowed the co-expression of Vif and the reporter gene (ZsGreen) from a single mRNA transcript. VSV-G pseudotyped lentiviruses were produced by transfection of packaging cells, Lenti-X 293T cells (Clontech). Viruses were then used to transduce MCF10A and HCC1806 breast cells. Transduced cells stably expressing fluorescent marker were isolated by Fluorescence Activated Cell Sorting (FACS-AriaIII). The isolated cells were expanded and characterized. RNA was extracted from the cell lines MCF10A-Vif and HCC1806-Vif, and cDNA synthesis was performed. Expression of Vif was confirmed by PCR amplification of cDNA and APOBEC3G, 3B and 3C expression levels were also confirmed by qRT-PCR (TaqMan Technology).

Results: We obtained high-titer of Vif delivering lentiviruses used to transduce the breast cells. FACS allowed us to obtain sorting populations with highly purified transduced cells (sorting populations with 97 to 99% purity). Characterization of the new cell populations showed that lentiviral constructs integrated either Vif1 or Vif2 genes into genomic DNA. Moreover, Vif genes are expressed in these populations with no significant effect on the mRNA levels of APOBEC3G, 3C, and 3B (∼1.5 to 2 fold increases).

Discussion and conclusions: The genomic DNA of MCF10A (normal breast cell line) and HCC1806 (breast cancer cell line) were modified with Vif gene (and ZsGreen gene) integration generating new stable breast cell lines. In the near future, we will be able to confirm or not that inhibition of APOBEC3 by Vif sensitize to chemotherapy the breast cancer cells, and hopefully decrease recurrent relapses. We believe that the use of Vif to inhibit APOBEC3 is a promising therapeutic tool model with application in breast cancer disease.

Acknowledgements

The authors acknowledge funding from FCT- PTDC/BIM-MEC/6631/2014 and Egas Moniz, CRL.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.